Rampal et al. performed a genomic analysis of 36 patients with MPN undergoing leukemic transformation and observed about 10% of IDH1 mutations and about 30% of IDH2 mutations; the majority of IDH2-mutant cases displayed a high variant allelic frequency [70]. This evidence concerns the gene IDH1 and myeloproliferative disorder.